SampleFacts
PrivateLast Round
Grant
Jan 15, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SampleFacts operates in Healthcare & Life Sciences and is based in Uppsala. Its latest recorded funding round was a VC Round in May 2025.
SampleFacts is a biotechnology company that has developed a blood sampling card technology intended to collect blood from dried blood spots.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SampleFacts Comparables
Compare SampleFacts with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capitainer | 87% | |
| DBS System SA | 86% | |
| Spot On Sciences | 83% |
For institutional investors. Book with your work email.
SampleFacts Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 15, 2026 | ||||
| VC Round | May 9, 2025 | ||||
| Seed | Jun 20, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SampleFacts Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nordic Science Investments | VC Round |
| Life Science Invest | VC Round |
| Vinnova | Grant |
| Stockholm Business Angels | VC Round |
| Uppsala University Invest | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 15, 2026
$14K grant received from Vinnova.
- May 9, 2025
$1.8M round led by Nordic Science Investments and STOAF III SciTech.
For institutional investors. Book with your work email.
SampleFacts Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SampleFacts's valuation, stock price, and market status.
Is SampleFacts a public or private company?
SampleFacts is a private company.
What is the current stock price of SampleFacts?
SampleFacts is a private company, so its shares have no public market price. Caplight tracks SampleFacts's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SampleFacts worth (valuation)?
Valuation information for SampleFacts is not publicly available.
Can I buy SampleFacts stock?
SampleFacts shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SampleFacts's last funding round?
SampleFacts's most recent funding round was Grant on January 15, 2026.
Who are the main investors in SampleFacts?
Key investors in SampleFacts include Nordic Science Investments, Life Science Invest, Stockholm Business Angels.
Will SampleFacts IPO soon?
No public IPO plans have been announced for SampleFacts.
How can I track SampleFacts secondary market activity?
Caplight tracks bids, offers, and trades in SampleFacts's shares on secondary markets.